🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy and safety of BGG492 used to treat migr...
Status
Completed
Location
California Clinical Trials, 1560 Chevy Chase Drive, Suite 140
Start Date
2009-04
Trial ID
NCT00892203
Treatments Being Tested
This long-term extension study will assess the safety, tolerability and eff...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-06
Trial ID
NCT01338805
Treatments Being Tested
This study will assess the efficacy of BGG492 as adjunctive treatment in pa...
Status
Withdrawn
Location
University of South Alabama
Start Date
2010-08
Trial ID
NCT01167335
This study will assess the efficacy and safety of BGG492 as adjunctive trea...
Status
Completed
Location
Barrow Neurological Clinics at St. Joseph's Hospital and MC
Start Date
2010-06
Trial ID
NCT01147003
To provide medical follow-up to patients exposed to BGG492 for more than 28...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-08
Trial ID
NCT02150213
To evaluate efficacy and safety of BGG492 versus placebo on moderate to sev...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-10
Trial ID
NCT01649050
This study will assess the efficacy of a two week treatment with BGG492 in ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-01
Trial ID
NCT01302873
This study will evaluate the efficacy of BGG492 in reducing the sensitivity...
Status
Completed
Location
Novartis Investigator Site
Start Date
2008-10
Trial ID
NCT00784212
This study will asses the safety and efficacy of BGG492 in reducing the sei...
Status
Completed
Location
Novartis Investigator Site
Start Date
2009-03
Trial ID
NCT00887861
Treatments Being Tested
It will provide a first evaluation of efficacy, safety and tolerability of ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-05
Trial ID
NCT01617941